[Home ] [Archive]   [ فارسی ]  
:: Main Online Submission Archive Current Issue In Press ::
:: Volume 12, Issue 5 (Jan 2011) ::
ZJRMS 2011, 12(5): 65-68 Back to browse issues page
Combination therapy of Avonex and doxycycline in patients with multiple sclerosis
Naser Sharafaddinzadeh , Nastaran Majdinasab , Majid Keyhanifard , Armaghan Moravej Aleali
, sharafaddinzadeh@yahoo.com
Abstract:   (9248 Views)

  Background : Multiple sclerosis is an inflammatory, chronic demyelinating disease of the central nervous system (CNS) with unknown etiology. Multiple sclerosis causes disability in young people . An Immunomodulatory drug like Avonex (IFN β1a) is used to prevent relapses or disease progression . The aim of this study is to evaluate efficacy of combination therapy (Avonex and doxycycline) with standard therapy (Avonex) in remitting-relapsing multiple sclerosis (RRMS).

  Materials and Method : A double blind clinical trial was conducted. During four-month study period, 46 patients with RRMS, under standard medication (Avonex), were entered into the study. Their EDSS score were between 1-5. They randomly allocated in to two study groups with 23cases in each arm (cases and controls). All cases were allocated to each group based on blocking method. They received Avonex only in control group and Avonex and doxycycline in case group. EDSS was measured in both groups in the beginning and at the end of study. First EDSS and EDSS scores at the end of first, second, third and fourth months in both groups were compared. Number and rate of clinical attacks and side effects of treatment were assessed in both groups.

  Results : In case group, there was significant changes between the first EDSS and final EDSS score, but there was not any statistically significant finding in control group after 4 months. There was no significant difference between case and control group in EDSS scores during four-month study period and there was not significant difference between case and control groups in clinical attacks. Combination therapy was well tolerated without additive side effects.

  Conclusion : It seems that combination of both Avonex and doxycycline in RRMS patients were effective, safe, and well tolerated. [ZJRMS, 12(5): 65-68]

Keywords: Multiple sclerosis, avonex, d oxycycline
Full-Text [PDF 190 kb]   (3073 Downloads)    
Type of Study: Research | Subject: Neurology
* Corresponding Author Address: 1. Assistant Professor of Neurology, Ahwaz Jundishapur University of Medical Sciences and Health Services, Ahwaz, Iran
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharafaddinzadeh N, Majdinasab N, Keyhanifard M, Moravej Aleali A. Combination therapy of Avonex and doxycycline in patients with multiple sclerosis. ZJRMS. 2011; 12 (5) :65-68
URL: http://zjrms.ir/article-1-814-en.html

Volume 12, Issue 5 (Jan 2011) Back to browse issues page
Zahedan Journal of Research in Medical Sciences
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 3840